Lupin Stock has started moving upwards after getting approval from USFDA for 3 of its plants. Presently, Lupin stocks has the lead of 2.11%, but the experts are expecting much hike today.
Aurobindo Pharma's 2 plants are under surveillance of USFDA and the company might have difficulties to get clearance from the USFDA. The Income Tax department has filed the case against the Aurobindo Pharma's promoters to have more assets than their income. After this news, the company's stock received a sudden fall today.
In Aviation shares, ATF prices has received the deduction of 13 and Jet Fuel prices has received the deduction of 12%.
Experts advice to Buy Lupin Ltd for target 1763.12 and Sell Aurobindo Pharma for target 798.46
Subscribe us for latest Equity Trading Tips, expert recommendation and market news updates.
0 comments:
Post a Comment